BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt - BMO Capital Terms It 'Clear Setback'

(MENAFN - AsiaNet News) The company said an independent safety board found that continuing the trial was unlikely to demonstrate efficacy and recommended terminating it. A separate mid-stage trial ...